6.15+0.49 (+8.66%)
at Fri, May 31, 2024, 4:00PM EDT - U.S. markets closed
Nasdaq Real Time Price
An Israeli company engaged in the development of human placental adherent stromal cells for commercial use.
pluri-biotech.com
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for ... Wikipedia
Stock price: PLUR (NasdaqCM) $6.15 +0.49 (+8.66%)
Fri, May 31, 2024, 4:00PM EDT